Jizuoni Deng
Biographic Data
| ID | 10040411 |
|---|---|
| NAME | Jizuoni Deng |
| GIVEN NAMES | Jizuoni |
| FAMILY NAME | Deng |
| SIGNATURE | DENG J |
| AFFILIATIONS | Shenyang Pharmaceutical University |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2026 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Analysis of nationwide availability of negotiated drugs in China’s National Reimbursement Drug List
Objective This study aims to evaluate the availability of Price-Negotiated Drugs under China’s National Reimbursement Drug List in healthcare institutions and designated retail pharmacies. Methods This cross-sectional study uses data from the National Health Insurance Service Platform (extracted in September 2025) to evaluate the availability of 383 National Negotiated Drugs in healthcare institutions and retail pharmacies nationwide. According t…
No prominent works on this page.
Analysis of nationwide availability of negotiated drugs in China’s National Reimbursement Drug List
Objective This study aims to evaluate the availability of Price-Negotiated Drugs under China’s National Reimbursement Drug List in healthcare institutions and designated retail pharmacies. Methods This cross-sectional study uses data from the National Health Insurance Service Platform (extracted in September 2025) to evaluate the availability of 383 National Negotiated Drugs in healthcare institutions and retail pharmacies nationwide. According t…
Access to medicines (1 works) · China (1 works) · Drug (1 works) · Health Policy (1 works) · Healthcare Systems and Reforms (1 works) · Incentive (1 works) · Medication Adherence and Compliance (1 works) · Pharmaceutical Economics and Policy (1 works) · Reimbursement (1 works)